Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Veracyte Inc (NASDAQ: VCYT) closed at $44.44 in the last session, up 1.76% from day before closing price of $43.67. In other words, the price has increased by $1.76 from its previous closing price. On the day, 0.68 million shares were traded. VCYT stock price reached its highest trading level at $45.36 during the session, while it also had its lowest trading level at $43.44.
Ratios:
We take a closer look at VCYT’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.57 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 60.98. For the most recent quarter (mrq), Quick Ratio is recorded 4.79 and its Current Ratio is at 5.08. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on December 05, 2024, Downgraded its rating to Neutral and sets its target price to $37 from $38 previously.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $50.
On October 16, 2024, UBS started tracking the stock assigning a Buy rating and target price of $43.UBS initiated its Buy rating on October 16, 2024, with a $43 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 02 ’25 when EASTHAM KARIN sold 10,000 shares for $40.30 per share. The transaction valued at 403,006 led to the insider holds 18,497 shares of the business.
KARIN EASTHAM bought 10,000 shares of VCYT for $396,000 on Jan 02 ’25. On Dec 13 ’24, another insider, Stapley Marc, who serves as the Chief Executive Officer of the company, sold 5,590 shares for $43.42 each. As a result, the insider received 242,737 and left with 307,345 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VCYT now has a Market Capitalization of 3444082176 and an Enterprise Value of 3130123776. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.10 while its Price-to-Book (P/B) ratio in mrq is 2.93. Its current Enterprise Value per Revenue stands at 7.359 whereas that against EBITDA is 71.117.
Stock Price History:
The Beta on a monthly basis for VCYT is 1.71, which has changed by 0.7220031 over the last 52 weeks, in comparison to a change of 0.23095727 over the same period for the S&P500. Over the past 52 weeks, VCYT has reached a high of $46.00, while it has fallen to a 52-week low of $18.61. The 50-Day Moving Average of the stock is 6.50%, while the 200-Day Moving Average is calculated to be 45.04%.
Shares Statistics:
According to the various share statistics, VCYT traded on average about 802.40K shares per day over the past 3-months and 852550 shares per day over the past 10 days. A total of 77.49M shares are outstanding, with a floating share count of 76.55M. Insiders hold about 1.22% of the company’s shares, while institutions hold 106.24% stake in the company. Shares short for VCYT as of 1736899200 were 3047480 with a Short Ratio of 3.80, compared to 1734048000 on 2547939. Therefore, it implies a Short% of Shares Outstanding of 3047480 and a Short% of Float of 4.38.
